ClinicalTrials.gg
Not yet recruitingNCT07408401Updated Feb 13, 2026

Exercise Program Combined With Ergonomic Training in Textile Workers

An interventional study of Supervised Exercise and Home exercise in Textile Worker, sponsored by Okan University. Not yet recruiting. Open to participants aged 18 Years to 60 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-02-13.

Sponsored by Okan University · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Primary completion was expected by May 2026, 6 months ago, but the record still lists the study as not yet recruiting.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
18 Years to 60 Years
Sex
All
01

Study summary

Most studies in the literature focus on musculoskeletal disorders and pain levels in occupational groups with repetitive workloads, such as textile workers. However, due to the nature of the work environment, decreased respiratory function and postural disorders are also frequently observed in these individuals. There is no comprehensive study in the literature that combines respiratory exercises, posture training, and ergonomics training for textile workers. Therefore, this study will examine the effects of a regular exercise program implemented alongside ergonomics training provided to textile workers on respiratory parameters, musculoskeletal disorders, posture, functionality, pain levels, and fatigue intensity.

02

Conditions studied

  • Textile Worker

Keywords

  • breathing exercise
  • posture exercise
  • textile workers
  • ergonomics
03

In context

Lead sponsor

Okan University is the lead sponsor of 97 studies on the registry; 13 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 60 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

Volunteers aged 18-60 who have been working in the textile industry for at least 6 months will be included in the study.

Exclusion criteria

Exclusion Criteria:

  • Individuals with orthopedic or neurological conditions that prevent exercise,
  • those with chronic pulmonary disease, those with psychological disorders, and
  • those who have undergone surgery that prevents exercise will not be included in the study.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
60 participants (estimated)

Study arms

  • Active comparator
    Home exercise group

    This group will receive a brochure containing an exercise program they can do at home, along with training on ergonomics and posture.

    Other: Home exercise

  • Experimental
    Supervised group

    In this group, ergonomics and posture training will be taught in person, and exercise applications will be carried out in the form of supervised group exercises.

    Other: Supervised Exercise

  • No intervention
    Control Group

    In this group, no applications will be made; only assessments will be conducted at the beginning and end of the work.

Interventions

  • OtherSupervised Exercise

    Supervised exercise (breathing and chair-based exercise) with ergonomic and posture training

  • OtherHome exercise

    Home exercise with ergonomic and posture training

06

What researchers measure

Primary outcomes

  1. Respiratory Function

    A spirometer is an objective device used to measure lung air volumes and flow rates. This test is performed by the individual taking a deep breath and then blowing out forcefully, yielding various parameters. Spirometry results help identify obstructive (e.g., COPD, asthma) or restrictive (e.g., fibrosis) types of respiratory dysfunction. It is frequently used in clinical and occupational health settings, particularly to monitor respiratory function in individuals working in dusty environments such as textiles.

    Time frame: From enrollment to the end of treatment at 6 weeks

  2. Respiratory Function

    Chest circumference measurement: Chest circumference measurement is a simple, non-invasive method used to assess the effectiveness of the respiratory muscles and the mobility of the rib cage. In this measurement, a tape measure is used to determine the amount of change in chest circumference during inspiration (breathing in) and expiration.

    Time frame: From enrollment to the end of treatment at 6 weeks

  3. 6-Minute Walk Test

    The 6-Minute Walk Test is a practical and reliable field test used to assess an individual's submaximal aerobic capacity and functional exercise level. In the test, the participant walks as fast as possible, but at a safe pace, for 6 minutes on a flat corridor. The total distance covered during the test will be recorded in meters.

    Time frame: From enrollment to the end of treatment at 6 weeks

  4. Nordic Musculoskeletal System Questionnaire

    The Nordic Musculoskeletal System Questionnaire (NMQ) is a standardized self-report questionnaire developed to identify musculoskeletal disorders experienced by individuals in different body regions. It asks about pain, discomfort, or loss of function experienced in nine different body regions-neck, shoulder, back, waist, hip, knee, and wrist-over the past 12 months and the past 7 days. The questionnaire is widely used in the assessment of ergonomic risks and work-related musculoskeletal disorders. It is simple, quick to administer, and suitable for comparative analysis in large populations.

    Time frame: From enrollment to the end of treatment at 6 weeks

Secondary outcomes

  1. New York Posture Rating Chart

    The New York Posture Analysis is an observational assessment method used to systematically and objectively evaluate an individual's body posture. In this analysis, specific segments of the body such as the head, shoulders, torso, hips, knees, and ankles are observed from the front, side, and back, and 13 different posture regions are scored. Each region is scored between 1 and 5; high scores indicate better postural alignment, while low scores indicate postural abnormalities. Based on the total score, the individual's overall posture is classified as "good," "moderate," or "poor."

    Time frame: From enrollment to the end of treatment at 6 weeks

  2. Wall Push-Up Test

    The wall push-up test is a simple physical performance test used to assess upper extremity muscle strength and endurance. The participant places their hands shoulder-width apart on the wall and performs push-ups by flexing and extending their elbows while keeping their body in a straight line. The time taken to complete 5 repetitions will be recorded. The test is frequently used to measure the strength of the shoulder, arm, and chest muscles, as well as to assess upper body endurance.

    Time frame: From enrollment to the end of treatment at 6 weeks

  3. Sit-to-Stand Test

    The Sit-to-Stand Test is a performance test that evaluates lower extremity muscle strength, balance, and functional mobility. The participant sits down and stands up from a chair of standard height as many times as possible within 30 seconds, and the total number of repetitions will be measured. The test objectively determines lower extremity function and muscle endurance, which play an important role in daily living activities.

    Time frame: From enrollment to the end of treatment at 6 weeks

  4. Fatigue Severity Scale

    The Fatigue Severity Scale is a valid and reliable self-report measure developed to subjectively assess the level of fatigue that affects individuals' daily lives. This scale consists of a total of 9 items and uses a Likert-type rating system where each item is scored on a scale from 1 (strongly disagree) to 7 (strongly agree). Fatigue severity is determined by taking the average of the participant's total score; an increase in the average score indicates an increase in fatigue level.

    Time frame: From enrollment to the end of treatment at 6 weeks

  5. Visual Analog Scale

    A simple assessment tool that allows individuals to express the intensity of a feeling, pain, or symptom visually rather than numerically. It typically uses a horizontal line 10 cm long; one end of the line represents the minimum, such as "none" or "mildest," while the other end represents the maximum, such as 'unbearable' or "most severe." The participant marks the degree of pain or symptoms they feel on this line, and the position of the mark is measured in millimeters or centimeters to obtain a numerical value. In this study, it will be assessed three times: at rest, while working, and for night pain.

    Time frame: From enrollment to the end of treatment at 6 weeks

07

Study locations

No study locations are listed for this record.

08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Start is estimated for Feb 2026; primary completion for May 2026, 3 months later.

How these figures are worked out, and which studies are left out of them.

Registered
Jan 23, 2026
First posted
Feb 13, 2026
StartEst.
Feb 9, 2026
Primary completionEst.
May 15, 2026
CompletionEst.
Jun 30, 2026
Last update
Feb 13, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Feb 13, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT07408401
Lead sponsor
Okan University
Responsible party
Berna Çağla Balkışlı (Assistant Professor, Okan University) — Principal investigator
First posted
Feb 13, 2026
Start date
Feb 9, 2026 (estimated)
Primary completion
May 15, 2026 (estimated)
Completion
Jun 30, 2026 (estimated)
Last update
Feb 13, 2026

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Feb 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion